Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cancer Patients' Age-Related Benefits from Mobile Neurofeedback-Therapy in Quality of Life and Self-efficacy: A Clinical Waitlist Control Study.
Schmidt K, Krawutschke M, Kowalski A, Pasche S, Bialek A, Schweig T, Weismüller B, Tewes M, Schuler M, Hamacher R, Müller BW, Schadendorf D, Skoda EM, Teufel M, Fink M. Schmidt K, et al. Among authors: tewes m. Appl Psychophysiol Biofeedback. 2023 Jun;48(2):217-227. doi: 10.1007/s10484-022-09571-1. Epub 2022 Nov 18. Appl Psychophysiol Biofeedback. 2023. PMID: 36401150 Free PMC article.
Electronic Patient-Reported Outcome Measures (ePROMs) Improve the Assessment of Underrated Physical and Psychological Symptom Burden among Oncological Inpatients.
Warnecke E, Salvador Comino MR, Kocol D, Hosters B, Wiesweg M, Bauer S, Welt A, Heinzelmann A, Müller S, Schuler M, Teufel M, Tewes M. Warnecke E, et al. Among authors: tewes m. Cancers (Basel). 2023 Jun 1;15(11):3029. doi: 10.3390/cancers15113029. Cancers (Basel). 2023. PMID: 37296991 Free PMC article.
Neurofeedback Treatment Affects Affective Symptoms, But Not Perceived Cognitive Impairment in Cancer Patients: Results of an Explorative Randomized Controlled Trial.
Fink M, Pasche S, Schmidt K, Tewes M, Schuler M, Mülley BW, Schadendorf D, Scherbaum N, Kowalski A, Skoda EM, Teufel M. Fink M, et al. Among authors: tewes m. Integr Cancer Ther. 2023 Jan-Dec;22:15347354221149950. doi: 10.1177/15347354221149950. Integr Cancer Ther. 2023. PMID: 36691908 Free PMC article. Clinical Trial.
Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastatic breast cancer patients.
Welt A, Tewes M, Aktas B, O Hoffmann O, Wiesweg M, Ting S, Reis H, Worm K, Richly H, Hense J, Palmer MR, Lee BH, Wendling J, Kossow J, Scheulen ME, Lehnerdt C, Kohl M, Derks C, Skottky S, Haus U, Schmid KW, Kimmig R, Schuler M, Kasper S. Welt A, et al. Among authors: tewes m. Breast Cancer Res Treat. 2013 Nov;142(1):81-8. doi: 10.1007/s10549-013-2718-4. Breast Cancer Res Treat. 2013. PMID: 24122392
Establishment of a multimarker qPCR panel for the molecular characterization of circulating tumor cells in blood samples of metastatic breast cancer patients during the course of palliative treatment.
Bredemeier M, Edimiris P, Tewes M, Mach P, Aktas B, Schellbach D, Wagner J, Kimmig R, Kasimir-Bauer S. Bredemeier M, et al. Among authors: tewes m. Oncotarget. 2016 Jul 5;7(27):41677-41690. doi: 10.18632/oncotarget.9528. Oncotarget. 2016. PMID: 27223437 Free PMC article.
100 results